(Q27008952)

dipeptidyl peptidase-4 inhibitors

28 September 2019

2 references

2 October 2019

30 January 2021

1 reference

10 October 2019

1 reference

1 reference

2 references

25 January 2021

Hongyu Wang

1

1 reference

Crossref

Jinbo Liu

series ordinal

2

1 reference

Crossref

Hongwei Zhao

series ordinal

3

1 reference

Crossref

language of work or name

1 reference

2015

1 reference

Drug Design, Development and Therapy

30 January 2015

14 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

18 June 2019

19 June 2019

17 September 2019

28 September 2019

2 October 2019

10 October 2019

25 January 2021

30 January 2021

4 February 2021

20 October 2022

15 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

18 June 2019

19 June 2019

17 September 2019

28 September 2019

2 October 2019

10 October 2019

25 January 2021

30 January 2021

4 February 2021

20 October 2022

9

1 reference

page(s)

683-6

1 reference

Creative Commons Attribution-NonCommercial

copyright license

14 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

18 June 2019

19 June 2019

17 September 2019

28 September 2019

2 October 2019

10 October 2019

25 January 2021

30 January 2021

4 February 2021

20 October 2022

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Prevalence and control of diabetes in Chinese adults

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Descriptive study of possible link between cardioankle vascular index and homocysteine in vascular-related diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Aortic stiffness: current understanding and future directions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Long-term effects of intensive glucose lowering on cardiovascular outcomes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Alogliptin: a novel molecule for improving glycemic control in type II diabetes mellitus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Prevalence of diabetes among men and women in China

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Aortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Epidemiology of cardiovascular complications in type 2 diabetes mellitus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

[The design and baseline characteristics of a phase III study to evaluate the efficacy and safety of alogliptin versus placebo in type 2 diabetes mellitus in Mainland China].

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Arterial stiffness evaluation by cardio-ankle vascular index in hypertension and diabetes mellitus subjects

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Intensive glycemic control in the ACCORD and ADVANCE trials

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

The relationship between pulse wave velocity and pulse pressure in Chinese patients with essential hypertension.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322603

Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study

28 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25678772